Autosomal dominant polycystic kidney disease: pathophysiology and treatment.
Rapoport
J
J
Department of Nephrology & Hypertension, Kaplan Medical Center, POB 1, Rehovot 76100, Israel. jayson_r@clalit.org.il
D065092:Antidiuretic Hormone Receptor Antagonists; D000959:Antihypertensive Agents / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008565:Membrane Proteins / Q000235:genetics / Q000502:physiology; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use; D016891:Polycystic Kidney, Autosomal Dominant / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology*; D050396:TRPP Cation Channels
D065092:Antidiuretic Hormone Receptor Antagonists; D000959:Antihypertensive Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008565:Membrane Proteins; D016376:Oligonucleotides, Antisense; D050396:TRPP Cation Channels